Budget Impact Analysis of <i>EGFR</i> Mutation Liquid Biopsy for First- and Second-Line Treatment of Metastatic Non-Small Cell Lung Cancer in Greece

Within the European Union, Greece has the highest incidence of lung cancer among people under 45 years of age. Epidermal growth factor receptor (<i>EGFR</i>) tyrosine kinase inhibitors are indicated for the treatment of patients with <i>EGFR</i> mutation-positive metastatic n...

Full description

Bibliographic Details
Main Authors: Mindy Cheng, Athanasios Akalestos, Sidney Scudder
Format: Article
Language:English
Published: MDPI AG 2020-06-01
Series:Diagnostics
Subjects:
Online Access:https://www.mdpi.com/2075-4418/10/6/429